Goldman Sachs’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-302,168
Closed -$1.15M 5118
2024
Q4
$1.15M Buy
302,168
+285,862
+1,753% +$1.09M ﹤0.01% 3825
2024
Q3
$146K Buy
16,306
+532
+3% +$4.77K ﹤0.01% 4555
2024
Q2
$153K Buy
+15,774
New +$153K ﹤0.01% 4425
2024
Q1
Sell
-16,457
Closed -$180K 4775
2023
Q4
$180K Buy
16,457
+655
+4% +$7.17K ﹤0.01% 4361
2023
Q3
$162K Buy
15,802
+10,278
+186% +$105K ﹤0.01% 4303
2023
Q2
$87.2K Buy
5,524
+1,655
+43% +$26.1K ﹤0.01% 4589
2023
Q1
$87.5K Buy
3,869
+1,120
+41% +$25.3K ﹤0.01% 4690
2022
Q4
$98.1K Sell
2,749
-3,203
-54% -$114K ﹤0.01% 4678
2022
Q3
$232K Sell
5,952
-4,903
-45% -$191K ﹤0.01% 4658
2022
Q2
$521K Sell
10,855
-27,159
-71% -$1.3M ﹤0.01% 4353
2022
Q1
$3.51M Buy
38,014
+5,851
+18% +$541K ﹤0.01% 3087
2021
Q4
$7.14M Buy
32,163
+10,181
+46% +$2.26M ﹤0.01% 2536
2021
Q3
$7.61M Buy
21,982
+13,141
+149% +$4.55M ﹤0.01% 2483
2021
Q2
$3.32M Buy
8,841
+6,525
+282% +$2.45M ﹤0.01% 3093
2021
Q1
$720K Sell
2,316
-210
-8% -$65.3K ﹤0.01% 4132
2020
Q4
$632K Sell
2,526
-398
-14% -$99.6K ﹤0.01% 3701
2020
Q3
$540K Sell
2,924
-1,492
-34% -$276K ﹤0.01% 3635
2020
Q2
$1.1M Buy
4,416
+3,305
+297% +$826K ﹤0.01% 3164
2020
Q1
$201K Sell
1,111
-1,921
-63% -$348K ﹤0.01% 3937
2019
Q4
$1.26M Buy
3,032
+2,319
+325% +$967K ﹤0.01% 3194
2019
Q3
$180K Buy
713
+27
+4% +$6.82K ﹤0.01% 3938
2019
Q2
$273K Sell
686
-2,513
-79% -$1M ﹤0.01% 3754
2019
Q1
$1.72M Buy
+3,199
New +$1.72M ﹤0.01% 3017